I am new to IPO trading. I got one lot of Gautam allocated to me. In ICICI direct is shows as offline order, which I am not able to sell right now from ICICI portal. Can someone please guide me how to sell the stocks now.
🌅 Dehradun based real-estate developer, Pushpanjali Realms and Infratech is entering the capital market with its initial public offering. The issue, which will open on June 27, 2017 and will close on June 30, 2017.Pushpanjali Realms proposes to raise Rs 14.55 crores through the issue of 26,46,000 shares of face value of Rs. 10/- each for cash at a price of Rs. 55/- per equity share. The equity shares are proposed to be listed on the Emerge Platform of National Stock Exchange of India Limited (NSE). Sarthi Capital Advisors Pvt Ltd is the sole Lead Manager for the issue.
👤 Deepak Mittal, aged 40 years, is company''''s promoter and managing director. Mittal has more than 11 years in hospitality and real estate Industry.
😠Pushpanjali enjoys a sizeable and diverse portfolio of projects in Dehradun, Uttarakhand, where it plans to execute residential flats in range of 1BHK, 2BHK, 3 BHK and 4 BHK for customers across all income groups and spread in all over the city. Strategic locations of its projects in high economic growth areas strengthen the stability of its revenues streams and enhances its ability to close financing arrangements for its projects.
ðŸ¢ðŸ¡ðŸ¢Currently, the company has two ongoing projects in Dehradun, one is “Eminent Heights†with total area of 64,800 sq ft and second is “Orchid Park†with total land area of 2,02,500 sq ft. Both these projects have got all required clearances and are likely to be monetised over the next 12 to 18 months. Pushpanjali has built a strong established brand name in a short-time with a good execution track record
🎢Pushpanjali enjoys a strong financial track record. In the last four years between FY14 to FY17, the company has consistently improved its financial performance IN FY-14, it started with a small revenue base of Rs 1.16 crore which has multiplied over 18x to touch Rs 18.48 crs in December 31, 2016. Likewise, EBIDTA from operations has also grown significantly from Rs 0.03 crs in FY14 to touch Rs 1.35 crore in in December 31, 2016. WHile net profit has grown from a small base from Rs 0.02 crs in FY14 to Rs 1.18 crs in December 31, 2016.
🛣All these improved operational metrics have got reflected in better return ratios of 19% ROCE and 20% ROE for the company as on FY17.
🤠Avinash Goraksakar research head at Joindre Capital says, ''''We believe that once the proposed IPO is completed the company’s capital structure will further get a boost with the overall leverage reducing and more equity funds being used for working capital and project financing purposes. Overall we expect the operational return ratios like ROCE and ROE to improve further by FY19 on the back of confirmed visibility of the company’s existing projects which would also clearly reflect in a significant higher Topline and bottomline ahead over the next two years.''''
ðŸ˜The ‘Affordable Housing for All’ is a critical policy agenda for the present Narendar Modi government. Building of 1.6 million homes was sanctioned in FY14 with a value of Rs. 41,723 crore. Approximately 11 crore houses is estimated to be required by 2022 of which 70% will be in the affordable segment. The potential investment required in this space is US$250 billion per annum as per a KPMG report thus implying a huge opportunity for HFCs focused on LMI segment.
🌉Also, the ‘100 Smart Cities’ government initiative is aimed at reshaping the urban landscape by making cities more affordable and livable. Each city selected under the scheme would be granted Rs. 100cr/year for five years.This presents a huge opportunity for the housing segment and especially for players like Pushpanjali which have positioned themselves very strongly in this segment.
Guys Remember Sheela Foam nobody applied @700 IPO saying its expensive & not a great biz it opened 42% it opened 42% gap up on listing day & today sits pretty @1400/ almost double the IPO price.. Fail to understand the logic if market can pay 50 PE multiple to RBL Bank, 90 PE multiple to Dmart why is 34X PE looking so expensive for ERIS which is 1000% domestic (Immune from US FDA issues, No debt on books, Tax free manufacturing facility till 2024).. Lets hope the market takes a wise & a sensible call on this Pharma stock which of course has merits on hand...
7 out of (last) 7 issues lead by Pantomath have given positive listing gains. Out of those 7, only Bohra is trading below the issue price now (by 15%). Other 6 are trading at current gains from 9% (Manomay) to 111%(Chemcrux).
Having said all these positives about Pantomath, still I feel that Gautam is an AVOID.
Pros: Lead by Pantomath. ROE is 16% (which is PAR) but ROCE is 43%. Book seems to be good (PB of 1.9 in this industry is something positive). Very small issue size (3.324 crore). so subscription could be higher.
Cons: DE ratio is 4.5 Cash-flow is stagnant (no cash flow in past two fiscals) Raw material cost is eating into the profit of the company (even though sales are good, still the net-profit remains same). Topline is still struggling. Bonus issue just before IPO (most of the SMEs are doing it nowadays) raising 2.25 crore
I''m NEGATIVE on this issue because of its inability to post higher profit despite of increasing sales. I''m worried that my money will be used by promoters to exit this script with huge profit.